KRAS and colonic neoplasm: However, contrast to the high frequency of BRAF mutation in CMS1 subtype and K-Ras mutation in CMS3 subtype colon cancer patients, there was no significant difference in the frequencies of BRAF and K-Ras mutation in CMS subtypes derived from colon cancer cell lines (Figure 1C).